loading

Yarrow Bioscience, Inc. Common Stock Azioni (YARW) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2026-06-30 2026-03-31 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
12.79%
0.097
0.086 0.069 0.202 0.084
Research and Development
3.55%
0.788
0.817 4.881 6.124 9.684
Costs And Expenses
18.02%
3.199
3.902 7.611 9.399 12.85
Operating Income/Loss
18.71%
-3.102
-3.816 -7.542 -9.197 -12.77
Income/Loss From Continuing Operations Before Tax
19.14%
-2.899
-3.585 -5.747 -8.603 -12.01
Income Tax Expense/Benefit
-
- - - 0.004
Income/Loss From Continuing Operations After Tax
19.14%
-2.899
-3.585 -5.747 -8.603 -12.01
Income/Loss From Discontinued Operations, Net Of Tax
-0.108
- -0.008 -0.008 -0.008
Net Income/Loss
16.12%
-3.007
-3.585 -5.755 -8.611 -12.02
Basic Average Shares
97.99%
0.858
42.77 42.76 42.67 -
Diluted Average Shares
97.99%
0.858
42.77 42.76 42.67 -
Basic Earnings Per Share
4,287%
-3.51
-0.08 -0.13 -0.20 -
Diluted Earnings Per Share
4,287%
-3.51
-0.08 -0.13 -0.20 -
$7.50
price up icon 1.35%
$10.27
price up icon 0.39%
$5.74
price up icon 5.03%
$18.93
price up icon 5.17%
$10.91
price up icon 6.03%
WVE WVE
$3.19
price up icon 3.24%
Capitalizzazione:     |  Volume (24 ore):